US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 5.610
- -0.170-2.94%
Close Nov 29 13:00 ET
- 5.630
- +0.020+0.36%
Post 17:01 ET
474.96MMarket Cap-2280P/E (TTM)
5.835High5.560Low549.05KVolume5.800Open5.780Pre Close3.10MTurnover0.98%Turnover RatioLossP/E (Static)84.66MShares19.34052wk High0.93P/B313.82MFloat Cap4.30552wk Low--Dividend TTM55.94MShs Float78.000Historical High--Div YieldTTM4.76%Amplitude4.305Historical Low5.655Avg Price1Lot Size
About Verve Therapeutics Company
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Company Profile
SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sekar Kathiresan, M.D.
- Chief Executive Officer and Director
- 9.32M
- Andrew D. Ashe, J.D.
- President and Chief Operating Officer
- --
- Frederick Fiedorek, M.D.
- Chief Medical Officer
- --
- Troy Lister, PhD
- Chief Scientific Officer
- --
- Joan Nickerson
- Chief Administrative Officer
- --
- Allison Dorval
- Chief Financial Officer and Principal Accounting Officer
- 3.48M
- Dr. Ourania Tatsis, PhD
- Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
- --
- Dr. Burt A. Adelman, M.D.
- Chairman of the Board
- 451.88K
- Sheila Mikhail, J.D.
- Independent Director
- 412.38K
- Jodie P. Morrison
- Independent Director
- --
- Dr. Krishna Yeshwant, M.D.
- Independent Director
- 410.88K
- Lonnel Coats
- Independent Director
- 407.38K
- Michael F. Maclean
- Independent Director
- 521.07K
- Alexander G. Cumbo
- Independent Director
- 405.88K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data